Safe Orthopaedics SA (EPA:ALSAF)

Market Cap	56.10K -74.4%
Revenue (ttm)	5.04M -2.9%
Net Income	-1.93B
EPS	-0.93
Shares Out	91.22K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,010
Open	0.5600
Previous Close	0.6000
Day's Range	0.5600 - 0.6150
52-Week Range	0.5400 - 2.8000
Beta	-0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 10, 2026

About Safe Orthopaedics

Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was foun...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 77
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALSAF

Financial Performance

In 2024, Safe Orthopaedics's revenue was 5.04 million, a decrease of -13.24% compared to the previous year's 5.81 million. Losses were -1.93 billion, 839.1% more than in 2023.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 26, 2026

Data Sources Report a data error